Viyash Scientific Limited (VIYASH.NS)
NSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹214.87 (+3.37%) as of
Key statistics
- Market cap
- 94.83B
- P/E (TTM)
- 52.54
- Forward P/E
- 18.25
- EPS (TTM)
- 4.09
- Dividend yield
- 0.00%
- 52-week range
- 178.13 – 298.00
- Beta
- 0.98
- Revenue (TTM)
- 35.75B
- Profit margin
- 5.91%
- Analyst target
- ₹326.00
- Volume
- 1.46M
About Viyash Scientific Limited
Viyash Scientific Limited operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally. The company provides active pharmaceutical ingredients, finished dosage formulations, analytical services, and VET formulation services for cattle and poultry. The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026. The company was incorporated in 1985 and is headquartered in Hyderabad, India. Viyash Scientific Limited operates as a subsidiary of CA Harbor Investments.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Hyderabad, India
- Employees
- 2,900
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.